CS Paper Radar

Heterogeneity-Aware Deep Learning for Tumour Classification from Multiparametric MRI

Yue Xia, Euijoon Ahn, Tian Xia, Yuan Yuan, Michael Fulham, Jinman Kim

cs.CV ·submitted 2026-08-18 01:16 UTC · v1

Abstract

Intra-tumoural heterogeneity (ITH) reflects spatial variation in tumour biology and is an important determinant of tumour behaviour, prognosis, and treatment response. Radiomics and deep learning have shown promise for tumour classification from multiparametric MRI (mp-MRI), but radiomics relies on handcrafted features, while most deep learning methods use whole-tumour representations or manually defined sub-regions, limiting scalable modelling of tumour heterogeneity. We propose a Heterogeneity-Aware Deep Learning Classification (HA-DLC) framework that explicitly models imaging-derived tumour sub-regions for lesion-type diagnosis and molecular-status prediction. HA-DLC consists of: (1) a Heterogeneous Sub-region Generation (HSG) module that produces initial pseudo-labelled sub-regions via unsupervised clustering, followed by Cross-Patient Sub-region Alignment (CPSA), which maps cluster-derived regions to a shared label space using soft assignments; and (2) a Dual-Stream Feature Extraction (DSFE) module that integrates local heterogeneity-aware features with global tumour representations. Given the initial clustering masks, CPSA, segmentation, feature extraction, and classification are jointly optimized end-to-end using soft-target segmentation and classification objectives. We evaluate HA-DLC on the LLD-MMRI2023 liver lesion dataset and the RSNA-ASNR-MICCAI 2021 Radiogenomic Brain Tumour dataset. HA-DLC consistently outperforms state-of-the-art radiomics and deep learning baselines, demonstrating the value of cross-patient sub-region alignment and dual-stream heterogeneity modelling for tumour classification from mp-MRI.

Closest papers

Nearest neighbours by meaning across the whole index.

A Tumour-Aware Multimodal Framework for Explainable Prediction of IDH Mutation in Gliomas from Multi-Sequence MRI

eess.IV cs.CV ·2026-11-13 ·Tahsien Al-Quraishi, Waseem Alwan Zaboon, O. S. Albahri, Raza Nowrozy
similarity 0.73
Abstract · 45 pages, 12 figures, 4 tables. Preprint of an article submitted for consideration in International Journal of Information Technology & Deci…

Accurate prediction of isocitrate dehydrogenase (IDH) mutation status is essential for glioma diagnosis, prognosis, and treatment planning. Although recent deep learning approaches have demonstrated promising performance, many rely on whole-brain feature extraction and provide limited interpretability. This study proposes a tumour-aware multimodal framework for explainable, non-invasive prediction of IDH mutation status from multiparametric magnetic resonance imaging (MRI). The proposed framework integrates four MRI sequences (T1, T1CE, T2, and FLAIR), tumour subregion segmentation, quantitative radiomic descriptors, and clinical information within a unified deep learning architecture. An ablation study was conducted to evaluate the contribution of tumour-aware learning, radiomic features, and clinical variables. Model performance was assessed using multiple complementary evaluation metrics, including accuracy, precision, recall, F1-score, balanced accuracy, receiver operating characteristic analysis, confusion matrix evaluation, and Grad-CAM visualisation. Experimental results demonstrated that the proposed multimodal framework consistently outperformed the baseline MRI-only model, with the Clinical Fusion model achieving the strongest overall predictive performance. The integration of tumour-aware learning, radiomic descriptors, and clinical information progressively improved classification performance, while Grad-CAM visualisations indicated that the model predominantly focused on biologically relevant tumour regions. These findings suggest that tumour-aware multimodal feature integration enables accurate, interpretable, and non-invasive molecular profiling of gliomas and provides a promising foundation for future clinical decision support in precision neuro-oncology.

0.12

Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy Using Temporal Deep Learning on DWI

cs.AI ·2026-08-18 ·Pablo García Marcos, Md. Tarequl Islam, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez +3 more
similarity 0.71
Abstract

Early identification of non-responders to neoadjuvant chemotherapy (NACT) is crucial for timely treatment adaptation in breast cancer. However, many existing predictive models rely on multiparametric magnetic resonance imaging (MRI), late treatment time points, or extensive clinical data, which limits their applicability. This study proposes a deep learning framework for early prediction of pathological complete response (pCR) using only diffusion-weighted MRI (DW-MRI) acquired at baseline and after the first NACT cycle. This framework feeds cropped tumor-centered patches to an EfficientNet-based temporal model that directly learns tumor shape and local tissue characteristics without explicit radiomic feature engineering. The model, trained with 10-fold cross-validation, achieved an area under the receiver operating characteristic curve (AUC) of 0.90 for pCR prediction after one cycle, providing actionable information after a single treatment cycle while avoiding gadolinium administration and reducing dependence on heterogeneous clinical data. By focusing on the baseline-to-first-cycle window instead of later stages, the approach supports earlier escalation or de-escalation of NACT, and its exclusive reliance on DW-MRI facilitates protocol standardization, multi-centre deployment and privacy-preserving data sharing. These results demonstrate that DW-MRI-based deep learning on tumor-centered patches constitutes a minimally invasive, clinically deployable strategy for early pCR prediction, with direct implications for personalized treatment adaptation in neoadjuvant breast cancer therapy.

0.21

VGG16-MCA UNet: Whole-Tumor Segmentation in 2D FLAIR MRI with Decoder-Side Channel Attention

eess.IV cs.CV ·2026-09-20 ·Shubham Gajjar, Deep Joshi, Avi Poptani, Vishal Barot
benchmarktheorycode/data similarity 0.68
Abstract · 22 pages, 7 figures, 4 tables. Code and data splits: https://github.com/ShubhamGajjar/vgg16-mca-unet

Automated brain tumor segmentation supports diagnosis, treatment planning, and monitoring of disease progression, but building models that generalize across heterogeneous tumors and limited annotated data remains difficult. We present VGG16-MCA UNet, a hybrid architecture pairing an ImageNet-pretrained VGG16 encoder with a decoder in which a Multi-Channel Attention (MCA) module recalibrates features after each skip-connection fusion, trained with the Focal Tversky loss to counter severe foreground-background imbalance. We evaluate the model as a 2D, FLAIR-only, whole-tumor segmenter on tumor-positive slices from two public datasets: the BraTS 2020 benchmark and the LGG MRI Segmentation dataset. Using 5-fold cross-validation and a single network formed by averaging the weights of the five fold models, the method attains an aggregate pixel-level Dice (F1) of 95.10% on our held-out BraTS 2020 split and 88.32% on LGG. These scores are computed over all test pixels pooled into a single confusion matrix rather than averaged per case, and are therefore not directly comparable to the per-case mean Dice used in the BraTS challenge protocol. All partitions were drawn over individual slices rather than over patients, so every patient contributes slices to both training and test; the figures above therefore measure interpolation within known patients and should be read as an upper bound rather than as generalization to new ones. The model segments a 256x256 slice in 66.32 ms on a single 6 GB NVIDIA RTX 2060, approximately 8 ms more than an equivalent VGG16-UNet without MCA. We release the split records and report the protocol in full, with the aim of providing a precisely specified and reproducible 2D FLAIR baseline.

0.23

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.68
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19

Integrating Local Detail and Global Context: A Dual-Input Multi-Task Learning Framework for Bone Tumor Diagnosis

eess.IV cs.CV ·2026-09-23 ·S. M. Nasif Uddin, Rusab Sarmun, Muhammad E. H. Chowdhury, Adam Mushtak, Israa Al-Hashimi +1 more
similarity 0.67
Abstract

Primary bone tumors are rare but clinically aggressive neoplasms whose diagnosis from radiographs is challenged by heterogeneous morphology, subtle lesion margins, and overlapping bone structures. To address the limitations of existing single-view models, we present a dual-input, multi-task learning framework that, to our knowledge, is the first to apply bidirectional cross-modal attention between a lesion crop and the full radiograph for joint segmentation and subtype classification. Using the multi-institutional Bone Tumor X-ray Radiograph Dataset (BTXRD, n=3,746), we employ a YOLO-based detector to generate regions of interest, which are paired with full images as inputs to a dual-stream DenseNet121 architecture. Features are integrated via a novel cross-modal attention fusion strategy, refined by Hierarchical Multi-scale Feature Fusion, effectively balancing fine-grained lesion detail with global anatomical context. Evaluated on a held-out patient-level test split, the model demonstrates superior performance over single-input baselines, achieving an overall Dice Similarity Coefficient of 0.896 and a macro-averaged classification F1-score of 0.928. Notably, the system exhibits exceptional sensitivity for malignant osteosarcoma (AUC 0.999), validating the potential of dual-stream context modeling to support radiologists in accurate, early decision-making.

0.20

On the Role of MRI Sequences in Cross-Dataset Generalization for Brain Tumor Segmentation

cs.CV ·2026-08-30 ·Henrique Zan Grande, João G. Pitol, Lucas B. Schuck, Rafael V. Serenato, Rayson Laroca +1 more
publishedcode/data similarity 0.66
Abstract · Accepted for presentation at the 2026 Conference on Graphics, Patterns and Images (SIBGRAPI)

Brain tumor segmentation in magnetic resonance imaging (MRI) is a critical task for diagnosis and treatment planning. Despite the success of deep learning architectures such as U-Net and its variants, performance degradation across datasets remains a major challenge, particularly under domain shift and limited annotated data. To address this issue, this study systematically evaluates how individual MRI sequences influence model robustness across two well-known datasets. A ResUNet-based framework is employed, where each modality is trained independently to isolate its effect under a controlled cross-dataset evaluation protocol with tumor size stratification, without target-domain training, or with limited domain adaptation. Results show that the T2f/FLAIR sequence achieves the best cross-dataset performance, with Dice scores exceeding 75%. It consistently outperforms other modalities across most tumor size ranges, while multi-sequence training further improves performance. Additionally, even limited target-domain adaptation yields rapid initial gains, reducing the need for extensive annotations and costly retraining. Our source code is publicly available at https://github.com/henrique-zan/brain_tumor_segmentation/.

0.39

Lesion-Aware Adaptive Fourier Neural Operator for CT-to-PSMA PET Synthesis in Prostate Cancer

cs.CV physics.med-ph ·2026-08-11 ·Rashmi Bhaskara, Waleed M. Almutairi, Matthew Gopaulchan, Maram Musaad Alqurashi, Francis Asamoah +3 more
similarity 0.66
Abstract

Deep learning models that synthesize PET from CT or MRI can reduce patient dose and scanner demand, but are typically optimized with global losses such as L1 or mean squared error (MSE) that treat all voxels similarly. In whole-body PSMA-PET, tumor voxels occupy only a small fraction of the volume, yet carry the clinically relevant activity signal; as a result, models can achieve high structural similarity index measure (SSIM) and peak signal-to-noise ratio (PSNR) while still underestimating lesion activity or failing to preserve tumor-specific structure. Radiomics provides biologically meaningful descriptors of tumor intensity and texture, but direct radiomics conditioning is time-consuming because it requires feature extraction from delineated lesion regions. We propose LAFNO, a Lesion-Aware Adaptive Fourier Neural Operator for CT-to-PSMA-PET synthesis that replaces high-dimensional radiomics conditioning with two efficient CT-derived proxy channels. Motivated by radiomics analysis of PSMA-avid tumor core and peritumoral regions, LAFNO uses a contrast proxy for local density variation and a disorder proxy for local texture heterogeneity, both injected into the model bottleneck. LAFNO combines whole-volume reconstruction with lesion-level total lesion activity (TLA), tumor-core contrast, and peritumoral supervision. We evaluated LAFNO against four baseline architectures on the TCIA PSMA-PET-CT-Lesions dataset. LAFNO remained competitive on whole-volume image quality, achieving SSIM of 0.960 and 0.938 for 18F- and 68Ga-PSMA, respectively, while reducing per-patient TLA error to 48.3% and 64.0% for 18F- and 68Ga-PSMA, respectively, and achieving the highest tumor-core radiomics reproducibility across all feature classes for both tracers. Peritumoral reproducibility remained tracer-dependent, indicating that biological fidelity in synthetic PSMA-PET remains challenging.

0.04

Explainable and CPU-Efficient Brain Tumor Classification from MRI Using Two-Phase EfficientNetB3 Fine-Tuning

cs.CV ·2026-11-18 ·Deepro Das, Saad Kabir Uddin, Mohammad Alauddin, Bornali Sarker, Thasnim Akhter
similarity 0.66
Abstract · 6 pages, 5 figures, 6 tables

Brain tumors are among the most lethal neurological disorders, with over 308,000 new diagnoses annually worldwide. Accurate classification of tumor type from Magnetic Resonance Imaging (MRI) scans is critical for treatment planning; however, manual radiological interpretation is time-consuming and prone to inter-observer variability. This paper proposes an automated deep learning pipeline for four-class brain MRI classification (glioma, meningioma, no tumor, and pituitary tumor) using EfficientNetB3 transfer learning with a custom classification head. A two-phase training strategy is adopted: Phase 1 trains the head with a frozen backbone (best validation accuracy: 92.77%), and Phase 2 selectively fine-tunes the top 37 layers at a 100x reduced learning rate (best validation accuracy: 94.91%). On an independent balanced test set of 1,600 MRI images, the system achieves 90.62% overall accuracy and a macro-average AUC of 0.9854. Gradient-weighted Class Activation Mapping (Grad-CAM) is integrated for class-discriminative visual explainability. The proposed system simultaneously addresses three dimensions absent in prior work: high accuracy, CPU-only computational efficiency, and clinical interpretability.

0.14